Encephalomyelitis: Clinical Trials

1 trial for Encephalomyelitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1

Follow Encephalomyelitis: new trials by email Literature Review of Encephalomyelitis trials Research Report on Encephalomyelitis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine
VEE 3526 - Venezuelan Equine Encephalitis
Phase 1WithdrawnDynPort Vaccine Company LLC, A GDIT Company2005-07-012015-09-18

Narrower conditions

Encephalomyelitis, Venezuelan Equine (1)

Broader conditions

Alphavirus Infections (1)  ·  Arbovirus Infections (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Infections (1)  ·  Central Nervous System Viral Diseases (1)  ·  Encephalitis (1)  ·  Encephalitis, Arbovirus (1)  ·  Encephalitis, Viral (1)  ·  Encephalomyelitis, Equine (1)  ·  Infections (1)  ·  Infectious Encephalitis (1)  ·  Mosquito-Borne Diseases (1)  ·  Nervous System Diseases (1)

Sponsors

DynPort Vaccine Company LLC, A GDIT Company (1)

Countries

United States (1)